Pharmacovigilance Risk Assessment Committee (PRAC): 25-29 September 2017

EventHumanPharmacovigilance

French is available via eTranslation, the European Commission's machine translation service.

Translate to French | Important information about machine translation

Date

Lundi, 25 septembre 2017, Journée Entière

Lieu

European Medicines Agency, Amsterdam, the Netherlands

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Documents

Minutes of the PRAC meeting 25-29 September 2017

Adopted Reference Number: EMA/PRAC/782068/2017

English (EN) (1 Mo - PDF)

Première publication: Dernière mise à jour:
Voir

Agenda - PRAC draft agenda of meeting 25-29 September 2017

Draft Reference Number: EMA/PRAC/634126/2017

English (EN) (497.54 Ko - PDF)

Première publication: Dernière mise à jour:
Voir

Agenda - Public hearing: Valproate

Adopted

English (EN) (349.82 Ko - PDF)

Première publication: Dernière mise à jour:
Voir

Summary of the EMA public hearing on valproate in pregnancy

English (EN) (289.38 Ko - PDF)

Première publication: Dernière mise à jour:
Voir

Public hearing on valproate - Written interventions

Reference Number: EMA/645752/2017

English (EN) (599.03 Ko - PDF)

Première publication: Dernière mise à jour:
Voir

Public hearing on Valproate - Summary of safety concerns and list of questions for the public hearing on Valproate

English (EN) (74.09 Ko - PDF)

Première publication: Dernière mise à jour:
Voir

Multimedia

Share this page